stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Tango Therapeutics IncTNGX
$23.678.75%1.905

Tango Therapeutics Inc (TNGX)

Date: 2026-11-03 16:00O: 22.09H: 23.91L: 21.99C: 23.67Vol: 1.061M
Precedente Chiudi:
$21.76
Aprire:
$22.09
Volume 24 ore:
1,066,691
Volume relativo:
0.20
Capitalizzazione di mercato:
$3.99B
Reddito:
$56.99M
Utile/perdita netta:
-$107.23M
Rapporto P/E:
-
EPS:
-$0.8199
Flusso di cassa netto:
-$142.55M
1W Prestazione:
+3.39%
1M Prestazione:
+1.83%
6M Prestazione:
+12.80%
1Y Prestazione:
+195.44%
Intervallo 1D:
$21.99$23.91
Intervallo di 1 settimana:
$21.71$23.71
Portata 52W:
$7.37$34.39

Profilo aziendale di Tango Therapeutics Inc (TNGX)

Nome
Tango Therapeutics Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
(857) 320-4900
Indirizzo
201 BROOKLINE AVENUE, BOSTON, USA
Dipendente
137
X
-
Prossima data di guadagno
2026-11-03
Ultimi documenti SEC
SEC
Discussioni di TNGX su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Tango Therapeutics Inc Azioni (TNGX) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-10-16IniziatoWilliam BlairOutperform
2026-07-15IniziatoJP MorganOverweight
2026-06-26AggiornamentoJefferiesHold → Buy
2026-06-08AggiornamentoWolfe ResearchPeer Perform → Outperform

Tango Therapeutics Inc Azioni (TNGX) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312022-12-312022-12-312021-12-31
Revenue USD (M)62.3836.5336.5324.8637.04
Research and development USD (M)132.17115.20115.20105.9177.64
Operating expenses USD (M)173.67150.70150.70135.9395.23
Operating income USD (M)-111.29-114.17-114.17-111.07-58.19
Income before tax USD (M)-101.59-101.61-101.61-108.12-57.94
Income tax expense USD (M)0.000.130.130.050.29
Net income USD (M)-101.59-101.74-101.74-108.18-58.24
Basic EPS USD/shares-0.87-1.08-1.08-1.23-
Diluted EPS USD/shares-0.87-1.08-1.08-1.23-
Basic weighted shares shares (M)116.1794.5794.5787.82-
Diluted weighted shares shares (M)116.1794.5794.5787.82-

Tango Therapeutics Inc Azioni (TNGX) insider trading

  • ADAM CRYSTALNov 02 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $22.72
    #Azioni
    20,000
    Valore ($)
    454,400
    #Azioni Totale
    0
  • Crystal AdamOct 01 '26
    President, R&D
    Transazione
    Option Exercise
    Costo
    $5.20
    #Azioni
    27,000
    Valore ($)
    140,400
    #Azioni Totale
    142,743
  • Crystal AdamOct 01 '26
    President, R&D
    Transazione
    Sale
    Costo
    $24.47
    #Azioni
    27,000
    Valore ($)
    660,796
    #Azioni Totale
    115,743
  • Jessica NewcombSep 22 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $22.33
    #Azioni
    15,231
    Valore ($)
    340,108
    #Azioni Totale
    0
  • Newcomb JessicaSep 22 '26
    Principal Accounting Officer
    Transazione
    Sale
    Costo
    $24.22
    #Azioni
    8,200
    Valore ($)
    198,613
    #Azioni Totale
    59,121
  • Crystal AdamSep 01 '26
    President, R&D
    Transazione
    Sale
    Costo
    $22.37
    #Azioni
    27,000
    Valore ($)
    603,909
    #Azioni Totale
    115,743
  • Crystal AdamSep 01 '26
    President, R&D
    Transazione
    Option Exercise
    Costo
    $5.20
    #Azioni
    27,000
    Valore ($)
    140,400
    #Azioni Totale
    142,743
  • Crystal AdamAug 03 '26
    President, R&D
    Transazione
    Sale
    Costo
    $27.24
    #Azioni
    27,000
    Valore ($)
    735,517
    #Azioni Totale
    115,743
  • ADAM CRYSTALAug 03 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $27.18
    #Azioni
    81,000
    Valore ($)
    2,201,580
    #Azioni Totale
    0
  • Crystal AdamAug 03 '26
    President, R&D
    Transazione
    Option Exercise
    Costo
    $5.20
    #Azioni
    27,000
    Valore ($)
    140,400
    #Azioni Totale
    142,743
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
ADAM CRYSTALOfficerNov 02 '26Proposed Sale$22.7220,000454,4000
Crystal AdamPresident, R&DOct 01 '26Option Exercise$5.2027,000140,400142,743
Crystal AdamPresident, R&DOct 01 '26Sale$24.4727,000660,796115,743
Jessica NewcombOfficerSep 22 '26Proposed Sale$22.3315,231340,1080
Newcomb JessicaPrincipal Accounting OfficerSep 22 '26Sale$24.228,200198,61359,121
Crystal AdamPresident, R&DSep 01 '26Sale$22.3727,000603,909115,743
Crystal AdamPresident, R&DSep 01 '26Option Exercise$5.2027,000140,400142,743
Crystal AdamPresident, R&DAug 03 '26Sale$27.2427,000735,517115,743
ADAM CRYSTALOfficerAug 03 '26Proposed Sale$27.1881,0002,201,5800
Crystal AdamPresident, R&DAug 03 '26Option Exercise$5.2027,000140,400142,743

Tango Therapeutics Inc Borsa (TNGX) Ultime notizie

Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 25, 2026
Oct 25, 2026
Oct 24, 2026
Oct 24, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 20, 2026
Oct 20, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 16, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 13, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 11, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Oct 05, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 24, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 04, 2026
Sep 04, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026

Simile a TNGX